Evidence map›Paper›PMID 31329649›Full record

ArticlePloS one2019

Normal B cell development and Pax5 expression in Thy28/ThyN1-deficient mice.

Fusako Kitaura, Miyuki Yuno, Toshitsugu Fujita, Shigeharu Wakana, Jun Ueda, Kazuo Yamagata, Hodaka Fujii

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fusako KitauraChromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Osaka, Japan.
Miyuki YunoChromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Osaka, Japan.
Toshitsugu FujitaChromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Osaka, Japan.
Shigeharu WakanaTechnology and Development Team for Mouse Phenotype Analysis, RIKEN BioResource Research Center, Koyadai, Tsukuba, Ibaraki, Japan.
Jun UedaCenter for Genetic Analysis of Biological Responses, Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Japan.ORCID 0000-0002-9766-203X
Kazuo YamagataCenter for Genetic Analysis of Biological Responses, Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Japan.
Hodaka FujiiChromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Osaka, Japan.ORCID 0000-0003-1296-4256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thy28, also known as ThyN1, is a highly conserved nuclear protein. We previously showed that in a chicken mature B cell line, Thy28 binds to the promoter of the gene encoding Pax5, a transcription factor essential for B cell development, and positively regulates its expression. Here, we generated a Thy28-deficient mouse line to analyze its potential role in B cell development in mice. Thy28-deficient mice showed normal development of B cells, and the expression of Pax5 was comparable between wild-type and Thy28-deficient primary B cells. Thus, species-specific mechanisms regulate Pax5 expression and B cell development.

Indexed as

AnimalsB-LymphocytesFemaleMaleMiceMice, Inbred C57BLNuclear ProteinsPAX5 Transcription FactorNuclear ProteinsPax5 protein, mousePAX5 Transcription FactorThy28 protein, mouse

Identifiers

PMID31329649
PMCPMC6645560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.